Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets

被引:41
作者
Basile, Maria Sofia [1 ]
Mazzon, Emanuela [2 ]
Fagone, Paolo [1 ]
Longo, Antonio [3 ]
Russo, Andrea [3 ]
Fallico, Matteo [3 ]
Bonfiglio, Vincenza [3 ]
Nicoletti, Ferdinando [1 ]
Avitabile, Teresio [3 ]
Reibaldi, Michele [3 ]
机构
[1] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy
[2] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy
[3] Univ Catania, Dept Ophthalmol, Catania, Italy
关键词
uveal melanoma; inhibitory checkpoints; immunotherapy; immune-escape; immune-privilege; SINUSOIDAL ENDOTHELIAL-CELLS; GROWTH-FACTOR-BETA; MIGRATION INHIBITORY FACTOR; TUMOR-INFILTRATING LYMPHOCYTES; ANTERIOR-CHAMBER; INDOLEAMINE 2,3-DIOXYGENASE; NITRIC-OXIDE; PROGNOSTIC-SIGNIFICANCE; IMMUNE-SYSTEM; FAS LIGAND;
D O I
10.3389/fonc.2019.01145
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Uveal Melanoma (UM) represents the most common primary intraocular malignant tumor in adults. Although it originates from melanocytes as cutaneous melanoma, it shows significant clinical and biological differences with the latter, including high resistance to immune therapy. Indeed, UM can evade immune surveillance via multiple mechanisms, such as the expression of inhibitory checkpoints (e.g., PD-L1, CD47, CD200) and the production of IDO-1 and soluble FasL, among others. More in-depth understanding of these mechanisms will suggest potential targets for the design of novel and more effective management strategies for UM patients.
引用
收藏
页数:14
相关论文
共 140 条
[81]   Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells [J].
Lohse, AW ;
Knolle, PA ;
Bilo, K ;
Uhrig, A ;
Waldmann, C ;
Ibe, M ;
Schmitt, E ;
Gerken, G ;
ZumBuschenfelde, KHM .
GASTROENTEROLOGY, 1996, 110 (04) :1175-1181
[82]   Expression of MAGE, gp100 and tyrosinase genes in uveal melanoma cell lines [J].
Luyten, GPM ;
van der Spek, CW ;
Brand, I ;
Sintnicolaas, K ;
de Waard-Siebinga, I ;
Jager, MJ ;
de Jong, PTVM ;
Schrier, PI ;
Luider, TM .
MELANOMA RESEARCH, 1998, 8 (01) :11-16
[83]   Inflammatory Cytokines in Eyes with Uveal Melanoma and Relation with Macrophage Infiltration [J].
Ly, Long V. ;
Bronkhorst, Inge H. G. ;
van Beelen, Els ;
Vrolijk, Johannes ;
Taylor, Andrew W. ;
Versluis, Mieke ;
Luyten, Gregorius P. M. ;
Jager, Martine J. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (11) :5445-5451
[84]   Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma [J].
Maat, Willem ;
Ly, Long V. ;
Jordanova, Ekaterina S. ;
de Wolff-Rouendaal, Didi ;
Schalij-Delfos, Nicoline E. ;
Jager, Martine J. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (02) :505-510
[85]   Evidence for Natural Killer Cell-Mediated Protection from Metastasis Formation in Uveal Melanoma Patients [J].
Maat, Willem ;
van der Slik, Arno R. ;
Verhoeven, Dirk H. J. ;
Alizadeh, Behrooz Z. ;
Ly, Long V. ;
Verduijn, Willem ;
Luyten, Gregorius P. M. ;
Mulder, Arend ;
van Hall, Thorbald ;
Koning, Frits ;
Jager, Martine J. ;
van Bergen, Jeroen .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (06) :2888-2895
[86]   Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma [J].
Maio, M. ;
Danielli, R. ;
Chiarion-Sileni, V. ;
Pigozzo, J. ;
Parmiani, G. ;
Ridolfi, R. ;
De Rosa, F. ;
Del Vecchio, M. ;
Di Guardo, L. ;
Queirolo, P. ;
Picasso, V. ;
Marchetti, P. ;
De Galitiis, F. ;
Mandala, M. ;
Guida, M. ;
Simeone, E. ;
Ascierto, P. A. .
ANNALS OF ONCOLOGY, 2013, 24 (11) :2911-2915
[87]  
Mäkitie T, 2001, INVEST OPHTH VIS SCI, V42, P1414
[88]   The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K [J].
Maksimovic-Ivanic, Danijela ;
Mojic, Marija ;
Bulatovic, Mirna ;
Radojkovic, Milica ;
Kuzmanovic, Milos ;
Ristic, Slobodan ;
Stosic-Grujicic, Stanislava ;
Miljkovic, Djordje ;
Cavalli, Eugenio ;
Libra, Massimo ;
Fagone, Paolo ;
McCubrey, James ;
Nicoletti, Ferdinando ;
Mijatovic, Sanja .
LEUKEMIA RESEARCH, 2015, 39 (10) :1088-1095
[89]   Liver-Resident NK Cells: The Human Factor [J].
Male, Victoria .
TRENDS IN IMMUNOLOGY, 2017, 38 (05) :307-309
[90]  
Mangano Katia, 2018, Oncotarget, V9, P17951, DOI 10.18632/oncotarget.24885